J. C. Fuller, N. J. Burgoyne, and R. M. Jackson, Predicting druggable binding sites at the protein???protein interface, Drug Discovery Today, vol.14, issue.3-4, pp.155-161, 2009.
DOI : 10.1016/j.drudis.2008.10.009

C. M. Labbe, iPPI-DB: an online database of modulators of protein???protein interactions, Nucleic Acids Research, vol.44, issue.D1, pp.542-547, 2016.
DOI : 10.1093/nar/gkv982

M. J. Basse, S. Betzi, X. Morelli, and P. Roche, 2P2Idb v2: update of a structural database dedicated to orthosteric modulation of protein-protein interactions. Database: the journal of biological databases and curation, pp.10-1093, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01307114

H. Zhong, )-based irreversible protein???protein interaction inhibitor of BRD4 as a potent anticancer agent, Chemical Science, vol.141, issue.10, pp.5400-5408, 2015.
DOI : 10.1016/j.cell.2010.03.030

T. S. Kang, Identification of an Iridium(III)-Based Inhibitor of Tumor Necrosis Factor-??, Journal of Medicinal Chemistry, vol.59, issue.8, pp.4026-4031, 2016.
DOI : 10.1021/acs.jmedchem.6b00112

L. J. Liu, Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds, Oncotarget, vol.7, issue.12, pp.13965-139757369, 2016.
DOI : 10.18632/oncotarget.7369

S. Mignani, S. Kazzouli, M. M. Bousmina, and J. P. Majoral, Dendrimer Space Exploration: An Assessment of Dendrimers/Dendritic Scaffolding as Inhibitors of Protein???Protein Interactions, a Potential New Area of Pharmaceutical Development, Chemical Reviews, vol.114, issue.2, pp.1327-134210, 2014.
DOI : 10.1021/cr400362r

A. Mullard, Protein???protein interaction inhibitors get into the groove, Nature Reviews Drug Discovery, vol.468, issue.3, pp.173-175, 2012.
DOI : 10.1038/nature09504

M. R. Arkin, Y. Tang, and J. A. Wells, Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality, Chemistry & Biology, vol.21, issue.9, pp.1102-1114, 2014.
DOI : 10.1016/j.chembiol.2014.09.001

J. A. Wells and C. L. Mcclendon, Reaching for high-hanging fruit in drug discovery at protein???protein interfaces, Nature, vol.12, issue.7172, pp.1001-1009, 2007.
DOI : 10.1128/MCB.17.12.7040

C. M. Park, Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins, Journal of Medicinal Chemistry, vol.51, issue.21, pp.6902-6915, 2008.
DOI : 10.1021/jm800669s

A. J. Souers, ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets, Nature Medicine, vol.559, issue.2, pp.202-2083048, 2013.
DOI : 10.1038/leu.2009.151

R. Nussinov and C. J. Tsai, Unraveling structural mechanisms of allosteric drug action, Trends in Pharmacological Sciences, vol.35, issue.5, pp.256-264, 2014.
DOI : 10.1016/j.tips.2014.03.006

B. B. Aggarwal, Signalling pathways of the TNF superfamily: a double-edged sword, Nature Reviews Immunology, vol.3, issue.9, pp.745-756, 2003.
DOI : 10.1038/nri1184

R. M. Fleischmann, I. Iqbal, and R. L. Stern, Considerations with the use of biological therapy in the treatment of rheumatoid arthritis, Expert Opinion on Drug Safety, vol.1, issue.4, pp.391-403, 2004.
DOI : 10.1136/gut.50.2.206

A. Rubbert-roth and A. Finckh, Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review, Arthritis Research & Therapy, vol.11, issue.Suppl 1, p.1, 2009.
DOI : 10.1186/ar2666

M. M. He, Small-Molecule Inhibition of TNF-??, Science, vol.310, issue.5750, pp.1022-1025, 2005.
DOI : 10.1126/science.1116304

P. Alexiou, Rationally Designed Less Toxic SPD-304 Analogs and Preliminary Evaluation of Their TNF Inhibitory Effects, Archiv der Pharmazie, vol.227, issue.11, pp.798-80510, 2014.
DOI : 10.1038/227680a0

H. Choi, Y. Lee, H. Park, and D. S. Oh, Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.21, pp.6195-6198, 2010.
DOI : 10.1016/j.bmcl.2010.08.116

C. H. Leung, Structure-Based Repurposing of FDA-Approved Drugs as TNF-?? Inhibitors, ChemMedChem, vol.70, issue.5, pp.765-768, 2011.
DOI : 10.1124/mol.106.028480

F. Mancini, Inhibition of tumor necrosis factor-?? (TNF-??)/ TNF-?? receptor binding by structural analogues of suramin????Abbreviations: TNF-??, tumor necrosis factor-??; and MC/EM, MonteCarlo/energy minimization., Biochemical Pharmacology, vol.58, issue.5, pp.851-859, 1999.
DOI : 10.1016/S0006-2952(99)00150-1

R. Alzani, Suramin induces deoligomerization of human tumor necrosis factor alpha, J Biol Chem, vol.268, pp.12526-12529, 1993.
DOI : 10.1021/bi00019a012

D. S. Chan, Structure-Based Discovery of Natural-Product-like TNF-?? Inhibitors, Angewandte Chemie International Edition, vol.2, issue.16, pp.2860-2864, 2010.
DOI : 10.1002/asia.200700125

C. H. Leung, A Metal-Based Inhibitor of Tumor Necrosis Factor-??, Angewandte Chemie International Edition, vol.29, issue.36, pp.9010-901410, 2012.
DOI : 10.1002/(SICI)1097-0134(1997)1+<215::AID-PROT29>3.0.CO;2-Q

F. Buller, Discovery of TNF Inhibitors from a DNA-Encoded Chemical Library based on Diels-Alder Cycloaddition, Chemistry & Biology, vol.16, issue.10, pp.1075-1086011, 2009.
DOI : 10.1016/j.chembiol.2009.09.011

Z. Hu, Japonicone A antagonizes the activity of TNF-?? by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1, Biochemical Pharmacology, vol.84, issue.11, pp.1482-1491025, 2012.
DOI : 10.1016/j.bcp.2012.08.025

L. Ma, A Novel Small-molecule Tumor Necrosis Factor ?? Inhibitor Attenuates Inflammation in a Hepatitis Mouse Model, Journal of Biological Chemistry, vol.10, issue.18, pp.12457-1246610, 2014.
DOI : 10.1038/sj.bjp.0702747

C. Galanos, M. A. Freudenberg, and W. Reutter, Galactosamine-induced sensitization to the lethal effects of endotoxin., Proceedings of the National Academy of Sciences, vol.76, issue.11, pp.5939-5943, 1979.
DOI : 10.1073/pnas.76.11.5939

M. A. Freudenberg and C. Galanos, Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice, Infect Immun, vol.59, pp.2110-2115, 1991.

M. Saitakis, A. Dellaporta, and E. Gizeli, 3424 | DOI:10.1038/s41598-017-03427-z 30 Measurement of two-dimensional binding constants between cell-bound major histocompatibility complex and immobilized antibodies with an acoustic biosensor, Biophys J, vol.7108, issue.95, pp.4963-4971132118, 2008.

Y. Bergaoui, C. Zerrouki, N. Fourati, J. Fougnion, and A. Abdelghani, SH-SAW sensors: investigations on macromolecules effects on binding kinetic constants, The European Physical Journal Applied Physics, vol.134, issue.1, pp.13705-13709, 2011.
DOI : 10.1016/j.snb.2008.04.016

URL : https://hal.archives-ouvertes.fr/hal-00736288

N. Fourati and C. Zerrouki, Immunosensing with surface acoustic wave sensors: toward highly sensitive and selective improved piezoelectric biosensors. New sensors and processing chain, pp.978-979, 2014.
DOI : 10.1002/9781119050612.ch3

C. P. Papaneophytou, A. K. Mettou, V. Rinotas, E. Douni, and G. A. Kontopidis, Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-??/SPD304 Study, ACS Medicinal Chemistry Letters, vol.4, issue.1, pp.137-14110, 2013.
DOI : 10.1021/ml300380h

A. N. Jain, Surflex:?? Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine, Journal of Medicinal Chemistry, vol.46, issue.4, pp.499-511, 2003.
DOI : 10.1021/jm020406h

F. Calmon-hamaty, B. Combe, M. Hahne, and J. Morel, Lymphotoxin alpha revisited: general features and implications in rheumatoid arthritis, Arthritis Res Ther, vol.13, issue.232, pp.10-1186, 2011.
DOI : 10.1186/ar3376

URL : https://arthritis-research.biomedcentral.com/track/pdf/10.1186/ar3376?site=arthritis-research.biomedcentral.com

P. Neregard, Etanercept decreases synovial expression of tumour necrosis factor-?? and lymphotoxin-?? in rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.47, issue.2, pp.85-9010, 2014.
DOI : 10.1093/rheumatology/ken261

M. H. Buch, True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin ???, Annals of the Rheumatic Diseases, vol.63, issue.10, pp.1344-1346014878, 2003.
DOI : 10.1136/ard.2003.014878

E. F. Pettersen, UCSF Chimera?A visualization system for exploratory research and analysis, Journal of Computational Chemistry, vol.373, issue.13, pp.1605-1612, 2004.
DOI : 10.1002/jcc.20084

URL : http://www.cgl.ucsf.edu/home/tef/pubs/chimera.pdf

D. Lagorce, O. Sperandio, H. Galons, M. A. Miteva, and B. Villoutreix, FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects, BMC Bioinformatics, vol.9, issue.1, p.396, 2008.
DOI : 10.1186/1471-2105-9-396

URL : https://bmcbioinformatics.biomedcentral.com/track/pdf/10.1186/1471-2105-9-396?site=bmcbioinformatics.biomedcentral.com